2014 Oncology Nursing Drug Handbook

2014 Oncology Nursing Drug Handbook
ISBN-10
1284043932
ISBN-13
9781284043938
Category
Medical
Pages
1330
Language
English
Published
2013-11-22
Publisher
Jones & Bartlett Learning
Authors
Margaret Barton-Burke, Gail M. Wilkes

Description

Updated annually, this essential reference written especially for nurses caring for patients with cancer provides valuable information on effective symptom management, patient education and chemotherapy administration. (Oncology & Cancer)

Other editions

Similar books

  • 2020-2021 Oncology Nursing Drug Handbook
    By Margaret Barton-Burke, Gail M. Wilkes

    Written especially for nurses caring for patients with cancer, the 2020-2021 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for ...

  • 2017 Oncology Nursing Drug Handbook
    By Margaret Barton-Burke, Gail M. Wilkes

    Aslex Pharmaceutical Inc. Dacogen (decitabine) [package insert]. Dublin, CA. October 2014. Aspen Global Incorporated. Leukeran (chlorambucil) [package insert]. Grand Bay, Mauritius [distributed by Prasco Labs, Mason, OH]. February 2016.

  • Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice
    By MiKaela M. Olsen, Kristine B. LeFebvre, Kelly J. Brassil

    These guidelines explain and reference standards that oncology nurses should be aware of and follow. This book is an essential resource to enhance your care of patients with cancer.

  • 2018 Oncology Nursing Drug Handbook
    By Margaret Barton-Burke, Wilkes

    Loprinzi CL, Jensen M, Burnham N, et al. Body Composition Changes in Cancer Patients Who Gain Weight from Megestrol Acetate. Proc Am Soc Clin Oncol 1992; 11:378. Loprinzi CL, Kugler JW, Sloan JA, et al.

  • 2016 Oncology Nursing Drug Handbook
    By Margaret Barton-Burke, Wilkes

    Taplin ME, Montgomery RB, Logothetis C, et al. 2012; Effect of neoadjuvant abiraterone acetate (AA) plus leuprolide acetate (LHRHa) on PSA, pathological complete response (pCR), and near pCR in localized highrisk prostate cancer ...

  • 2020-2021 Oncology Nursing Drug Handbook
    By Margaret Barton-Burke, Gail M. Wilkes

    Written especially for nurses caring for patients with cancer, the 2020-2021 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for ...

  • 2015 Oncology Nursing Drug Handbook
    By Margaret Barton-Burke, Gail M. Wilkes

    Taplin M-E, Montgomery RB, Logothetis C, et al. 2012; Effect of neo-adjuvant abiraterone acetate (AA) plus leuprolide acetate (LHRHa) on PSA, pathological complete response (pCR), and near pCR in localized high-risk prostate cancer ...

  • Chemotherapy and Biotherapy Guidelines and Recommendations for Practice
    By Martha Polovich, Kristine B. LeFebvre, MiKaela Olsen

    This new edition of the Chemotherapy and Biotherapy Guidelines and Recommendations for Practice has been revised and updated to reflect the current procedures and practices in your specialty.

  • Mosby's Oncology Nursing Advisor
    By Susan Newton, Margie Hickey, Joyce Jackowski

    Ries L.A.G., Harkins D., Krapcho M.,et al. SEER Cancer statistics review, 1975-2003. Bethesda, MD:National CancerInstitute, 2006. Retrieved September 13,2007from http://seer.cancer.gov/csr/1975_2003/, based on November 2005 SEER data ...

  • Pediatric Oncology Nursing: Defining Care Through Science
    By Pamela S. Hinds, Lauri Linder

    This book presents the current state of the nursing science in topics relevant to the care of pediatric oncology patients and their families across the treatment trajectory and is framed within a precision health framework.